Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 12 May 2025

Drug stockpiling behavior and its impact on anxiety among the general public in the early stage after the lifting of China’s Zero-COVID policy: results from a web-based survey

in Pharmacoepidemiology

Yu Huang
Shuiyang Xu
Xiang Zhao
Lei Wang
Qiaohong Lv
Suxian Wu
Qingqing Wu
Xuehai Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1524068

Original Research

Published on 09 May 2025

Construction and validation of a meropenem-induced liver injury risk prediction model: a multicenter case-control study

in Pharmacoepidemiology

Yan He
Hongqin Ke
Jianyong Zhu
Xin Yuan
Hongliang Li
Wenwen Wu
Shuman Yang
Huibin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1542554

383 views

Original Research

Published on 06 May 2025

Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure: a retrospective examination of real-world cohort

in Pharmacoepidemiology

Aseel Sukik
Ahmed Tarek Aboughalia
Abdul Haseeb Said Wali
Amro Al Radaideh
Omar Mohamed Elsayed
Mohammed A. Amer
Joud Said Abuodeh
Oyelola A. Adegboye
AbdelNaser Elzouki
Mohammed Ibn-Mas‘ud Danjuma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1526112

531 views

Original Research

Published on 06 May 2025

Adherence and persistence with istradefylline treatment in patients with Parkinson’s disease in the United States

in Pharmacoepidemiology

Reversa Joseph
Joyce Qian
Hannah Cummings
Yen-Hua Chen
Shubham Tewari
Michael Soileau

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548631

770 views

Original Research

Accepted on 02 May 2025

Adverse Events Associated with Vismodegib: Insights from a Real-world Pharmacovigilance Study Using the FAERS Database

in Pharmacoepidemiology

Bingqing Wang
Kaidi Zhao
Ningyi Xian
Landong Ren
Jiashu Liu
Chen Tu
Dewu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1497708

Original Research

Published on 02 May 2025

An in-depth exploration of the association between olanzapine, quetiapine and acute pancreatitis based on real-world datasets and network toxicology analysis

in Pharmacoepidemiology

Shuang Wang
Liying Song
Yuanjie Sun
Haonan Zhou
Jia Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529416

561 views

Original Research

Published on 02 May 2025

Comprehensive analysis of adverse events associated with vortioxetine using the FDA adverse event reporting system

in Pharmacoepidemiology

Liangxia Li
Qianqian Xu
Liangfang Pang
Yarui Liu
Yuanyuan Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519865

440 views

Original Research

Accepted on 01 May 2025

Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects

in Pharmacoepidemiology

Anaelle Weissgerber
Maren Hermanns-Clausen
Evelyn Lamy

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571025

163 views

Original Research

Published on 30 Apr 2025

Post-marketing safety of anakinra and canakinumab: a real-world pharmacovigilance study based on FDA adverse event reporting system

in Pharmacoepidemiology

Hao Liu
Wei Yan
Jinsong Li
Dezhi Yan
Di Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1483669

386 views

Original Research

Published on 30 Apr 2025

Drug-associated infections and infestations in older adults with tumor necrosis factor-alpha inhibitors: a real-world retrospective and pharmacovigilance study

in Pharmacoepidemiology

Xihui Yu
Jiahong Zhong
Xuemei Zhuang
Zhuomiao Lin
Hongbo Fu
Yaofeng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533902

464 views

Original Research

Accepted on 28 Apr 2025

Evaluation of dermatologic adverse events associated with aromatase inhibitors: Insights from the FAERS database

in Pharmacoepidemiology

Yuan-yuan Wu
Qiong-lian Huang
Zhan-yang Luo
Xiao-yun Song
You-yang Shi
Sheng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529342

Original Research

Published on 28 Apr 2025

Prescribing characteristics and guideline concordance of antihypertensive western and Chinese patent medicine in Internet hospitals in China: a cross-sectional study

in Pharmacoepidemiology

Tiantian Zhou
Xing Liao
Jiaxin Zuo
Fang Han
Ruogu Meng
Lin Zhuo
Guozhen Liu
Jing Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1580787

404 views

Original Research

Published on 28 Apr 2025

Charting the COVID-19 vaccination journey in Saudi Arabia: Insights into post-vaccination adverse effects and immunization dynamics

in Pharmacoepidemiology

Gehad M. Subaiea
Nawaf Alkhateeb
Faisal Sahman
Abdulrahman Alsudayri
Abdulkarim M. Almudayni
Hamoud Alrashidi
Abdulrahman M Alshammari
Abdulwahab Alamri
Sultan Almuntashiri
Arshad Hussain

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561410

387 views

Original Research

Published on 28 Apr 2025

Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases

in Pharmacoepidemiology

Tao Wang
Zhiwei Cui
Yingyong Ou
Siyu Lou
Huayou Chen
Chengyu Zhu
Linmei Zhou
Fan Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1530697

356 views

Original Research

Published on 25 Apr 2025

Acute liver injury and diffuse subcutaneous pneumatosis following compound paracetamol and amantadine hydrochloride tablets poisoning: a case report

in Pharmacoepidemiology

Zhiwen Zhao
Bo Wang
Lanlan Cai
Xuefang Liu
Zhicheng Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1503449

548 views

Systematic Review

Published on 25 Apr 2025

Evaluating the efficacy of valproic acid in alcohol use disorder: a systematic analysis of clinical trials from ClinicalTrials.gov

in Pharmacoepidemiology

Fahad S. Alshehri

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1503035

582 views